[HTML][HTML] Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - BMC medicine, 2022 - Springer
Background Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial.
EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - BMC Medicine, 2022 - europepmc.org
Background Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
[HTML][HTML] Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven, WM Boek… - BMC …, 2022 - ncbi.nlm.nih.gov
Background Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
[PDF][PDF] Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - 2022 - toetsingonline.nl
Background Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
[PDF][PDF] Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - 2022 - edepot.wur.nl
Background: Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven… - BMC …, 2022 - researchinformation.amsterdamumc …
Background: Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - BMC Medicine, 2022 - library.wur.nl
Background: Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
[HTML][HTML] Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven… - BMC …, 2022 - bmcmedicine.biomedcentral.com
Prednisolone has been suggested as a treatment for olfactory disorders after COVID-19, but
evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone …
evidence is scarce. Hence, we aimed to determine the efficacy of a short oral prednisolone …
Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
EJA Schepens, EE Blijleven, WM Boek, S Boesveldt… - BMC Medicine, 2022 - research.wur.nl
Background: Prednisolone has been suggested as a treatment for olfactory disorders after
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …
COVID-19, but evidence is scarce. Hence, we aimed to determine the efficacy of a short oral …